Combination therapy with the CDK7 (super-enhancer) inhibitor THZ1 and the histone deacetylase inhibitor panobinostat synergistically reduces JMJD6, E2F2 and MYCN expression, inducing apoptosis in vitro and causing NB tumor regression in mice [110]. Here, MYCN is linked to neoplasm.